Reiner 2022 — Dapiglutide Attenuates Intestinal Insufficiency in Short Bowel Model

Journal of Parenteral and Enteral Nutrition

Julie Reiner, et al.

Summary

Preclinical work characterized dapiglutide as a long-acting dual GLP-1/GLP-2 agonist with intestinal trophic/barrier effects.

Study Details

Study Design

In vitro and murine preclinical study

Indication

Short bowel / intestinal insufficiency model

Intervention

Dapiglutide dual GLP-1/GLP-2 receptor agonist

Species

Animal